PPA
TAK icon

Parametric Portfolio Associates’s Takeda Pharmaceutical TAK Stock Holding History

Parametric Portfolio Associates’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$61M Buy
4,256,356
+861,118
+25% +$12.6M 0.03% 499
2021
Q4 		$46.3M Sell
3,395,238
-607,917
-15% -$8.53M 0.02% 593
2021
Q3 		$65.6M Buy
4,003,155
+230,618
+6% +$3.87M 0.04% 453
2021
Q2 		$63.5M Sell
3,772,537
-64,757
-2% -$1.1M 0.04% 473
2021
Q1 		$70.1M Buy
3,837,294
+319,168
+9% +$5.74M 0.04% 437
2020
Q4 		$64M Sell
3,518,126
-57,379
-2% -$1.01M 0.04% 425
2020
Q3 		$63.8M Buy
3,575,505
+81,293
+2% +$1.48M 0.05% 360
2020
Q2 		$62.7M Buy
3,494,212
+120,695
+4% +$2.17M 0.05% 343
2020
Q1 		$51.2M Sell
3,373,517
-126,470
-4% -$2.29M 0.05% 356
2019
Q4 		$69.1M Buy
3,499,987
+341,063
+11% +$6.53M 0.05% 336
2019
Q3 		$54.3M Buy
3,158,924
+411,338
+15% +$7.11M 0.04% 394
2019
Q2 		$48.6M Sell
2,747,586
-565,410
-17% -$10.3M 0.04% 439
2019
Q1 		$67.5M Buy
3,312,996
+1,771,039
+115% +$35.6M 0.06% 303
2018
Q4 		$25.9M Buy
+1,541,957
New +$26M 0.03% 649

Other funds holding TAK

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Parametric Portfolio Associates's TAK Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Takeda Pharmaceutical (TAK) stake by 25% in Q1 2022, buying an estimated $12.6M and bringing the position to 4,256,356 shares worth $61M. The position accounts for 0.03% of the portfolio, ranked #499.

Parametric Portfolio Associates first reported a position in TAK in Q4 2018 and has held it in 14 quarters since. The position peaked at $70.1M in Q1 2021. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

  • Parametric Portfolio Associates held 4,256,356 shares of Takeda Pharmaceutical worth $61M as of Q1 2022.
  • Parametric Portfolio Associates bought 861,118 Takeda Pharmaceutical shares in Q1 2022, an estimated $12.6M.
  • Takeda Pharmaceutical made up 0.03% of Parametric Portfolio Associates's portfolio in Q1 2022, its #499 holding.
  • Parametric Portfolio Associates first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 14 quarters since.
  • Parametric Portfolio Associates's Takeda Pharmaceutical position peaked at $70.1M in Q1 2021.
  • 288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.